Talking biopharmaceuticals, biotechnology, bioprocessing and related pharma manufacturing.
Joined March 2011
- Tweets6.7K
- Following282
- Followers3.6K
- Likes144
BioPharm Intl retweeted
NEW! BioPharma By the Numbers infographic series from @BioPharmIntl - data-driven look at @BioPlanInc's 22nd Annual Report featuring key sectors, trends, and topics in the biopharma industry. First up - Rise in Bioprocessing Automation!
rb.gy/1x5ot9
BioPharm Intl retweeted
Latest survey of professionals in bio/#Pharmaceutical industry garnered ~90 completions that reveal the profound impact on operations and supply chains! Dive into the full survey results here: pharmtech.com/view/biopharma…
#supplychainsecurity #BioPharma #Tariffs #SupplyChain #Biotech
BioPharm Intl retweeted
9 Implications of #Trump’s Tax-Cut and Spending Bill for the Bio/#Pharmaceutical Industry biopharminternational.com/vi…
#Biopharmaceutical #BigBeautifulBill #pharma
BioPharm Intl retweeted
A survey of key opinion leaders at the 2025 @BIOConvention yielded a variety of responses and speculation about the future.
hubs.li/Q03v3MhJ0
BioPharm Intl retweeted
In this feature with @BioPharmIntl, our SVP and Head of Therapeutics Development, Sandra Visser, PhD, shares how Alltrna is pioneering a first-in-class platform to engineer tRNAs that read through shared genetic mutations and restore full-length protein production – without altering the genome.
Engineered tRNAs represent a fundamentally different, disease-agnostic approach with the potential to treat thousands of rare and ultra-rare conditions.
Explore the article on page 14 of this ebook on Next Generation Biotherapeutics: biopharminternational.com/vi…
#tRNA #tRNAmedicines #rarediseases #raredisease #StopCodonDisease
BioPharm Intl retweeted
Among other stipulations in a new executive order, the White House is directing @US_FDA to increase fees for and inspections of foreign drug manufacturing plants, and reduce the time required to approve newly constructed sites in the US. hubs.li/Q03lx0WL0
BioPharm Intl retweeted
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions
biopharminternational.com/vi…
#Cancer #Radiotherapeutic #ClinicalTrials #SupplyChain $PSTV @BioPharmIntl
BioPharm Intl retweeted
Director of Product Management, Jay Harp and Director of New Products, Tim Korwan share the benefits of single-use systems in this @BioPharmIntl article.
ow.ly/C3EM50NBzE1
#AvantorSetsScienceInMotion #SingleUse #Biopharma #Innovation
BioPharm Intl retweeted
Check out this new article published in @BioPharmIntl from members of our ElevateBio BaseCamp team on how to develop a robust and scalable lentiviral vector platform. biopharminternational.com/vi… #viralvector #genetherapy #LentiPeak
BioPharm Intl retweeted
.@BioPharmIntl discusses cold chain best practices and other CGT advancements with top industry experts.
#coldchain #CGT #biologics #-70PCM #PCM #phasechangematerial
biopharminternational.com/vi…
BioPharm Intl retweeted
What impact will the next wave of cell and gene therapies have in the years ahead?
@BioPharmIntl outlines which factors will help determine clinical success by highlighting perspectives from sector executives, including ARM CEO Tim Hunt. biopharminternational.com/vi…
BioPharm Intl retweeted
In @BioPharmIntl's recent article, "Optimizing Vectors to Standardize Success," Emily Moran examines how improvement in viral vector yield is integral for the development of cell and gene therapies.
Learn the keys to improving yield here: biopharminternational.com/vi…
BioPharm Intl retweeted
Ever wondered why #AAV capsid #titer is important in #bioprocessing? Listen to our latest podcast to learn more. Ian Kylov, Product Manager at Sartorius, is interviewed by @BioPharmIntl: ow.ly/RNoM50MtGMQ
#OctetBLI #genetherapy #bioprocessing #ELISA #adenoassociatedvirus
BioPharm Intl retweeted
Check out this @BioPharmIntl article featuring Matt Panning, our Senior Director of Manufacturing, talking about how the digitilization of bioprocessing is benefiting our operation and the #biotech industry as a whole.
biopharminternational.com/vi…
BioPharm Intl retweeted
As manufacturers continue on the path to #digitaltransformation, the application of machine learning, AI, and subject matter expertise can provide significant operational and financial benefits. Read our latest article in @BioPharmIntl to learn more: biopharminternational.com/vi…
BioPharm Intl retweeted
Check out this @BioPharmIntl article that provides insight from several Umoja experts on biochemicals and raw materials in #UpstreamProcessing and what industry professionals should know about this space. Read the full article here: bit.ly/3DpmiUs
BioPharm Intl retweeted
Sophia Percival, Catalent's Director of Drug Product Manufacturing, discusses how the changing #biopharmaceutical pipeline has placed pressure on fill/finish capacity and capabilities across the sector in this @BioPharmIntl article: ow.ly/FPZR50LhoMC
#fillfinish #biologics
BioPharm Intl retweeted
Our Cell and Gene Therapy experts shared their insights with @BioPharmIntl on adventitious agent testing for viral vectors and best practices for selecting the appropriate testing method. Learn more here: biopharminternational.com/vi…
BioPharm Intl retweeted
The market for #cellandgene therapies is expected to reach more than $36 billion by 2027. Matt Hewitt discusses key considerations to manufacture these therapeutics at a cost that balances revenue with affordability with @BioPharmIntl. Read more:
bit.ly/3C1qPwS
BioPharm Intl retweeted
Lonza’s #Biologics expert Carrie Mason shares her insights on how to streamline the bulk manufacture of monoclonal antibodies with @BioPharmIntl. Read how processes with Quality by Design can help create consistent antibodies for commercial scale up. bit.ly/3qryE8x
